Inventor
INGRID TEIGE
Inventor
SE
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C12NMicroorganisms or enzymes4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,527,866Combined use of Fc gamma RIIb (CD32B) and CD20 specific antibodies202612,441,805Antagonistic anti-TNFR2 antibodies202512,371,498Combination and use of antibodies202512,344,673Medicaments, uses and methods202512,291,569Antibodies and nucleotide sequences, and uses thereof202512,139,547Agonistic anti TNFR2 antibody molecules202411,623,005Combined use of FcgRIIb (CD32B) and CD20 specific antibodies202311,447,549Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BIOINVENT INT AB (6)· patent assignee history
2022Patents assigned to CANCER RESEARCH TECH LTD (1)· patent assignee history
2022–2026Based in SE· patent location history
2023–2026Patents assigned to UNIV SOUTHAMPTON (3)· patent assignee history
2025Patents assigned to BIOVENT INT AB (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOINVENT INT AB | 6 | 2022–2025 |
| UNIV SOUTHAMPTON | 3 | 2023–2026 |
| BIOVENT INT AB | 1 | 2025 |
| CANCER RESEARCH TECH LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| SE | 8 | 2022–2026 |